Carcinoma NOS Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Carcinoma / Carcinomas / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Cancer / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0044642 (Carcinoma NOS)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02376699Safety Study of SEA-CD40 in Cancer PatientsTreatment